A detailed history of Onyx Bridge Wealth Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Onyx Bridge Wealth Group LLC holds 15,311 shares of BMY stock, worth $884,363. This represents 0.12% of its overall portfolio holdings.

Number of Shares
15,311
Previous 16,292 6.02%
Holding current value
$884,363
Previous $676,000 17.16%
% of portfolio
0.12%
Previous 0.11%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$39.66 - $51.75 $38,906 - $50,766
-981 Reduced 6.02%
15,311 $792,000
Q2 2024

Jul 22, 2024

BUY
$40.25 - $52.99 $25,760 - $33,913
640 Added 4.09%
16,292 $676,000
Q1 2024

Apr 29, 2024

BUY
$47.98 - $54.4 $439,880 - $498,739
9,168 Added 141.39%
15,652 $848,000
Q4 2023

Jan 31, 2024

SELL
$48.48 - $57.85 $35,972 - $42,924
-742 Reduced 10.27%
6,484 $332,000
Q3 2023

Oct 16, 2023

BUY
$57.89 - $64.73 $84,345 - $94,311
1,457 Added 25.26%
7,226 $419,000
Q2 2023

Jul 25, 2023

BUY
$63.71 - $70.74 $92,698 - $102,926
1,455 Added 33.73%
5,769 $368,000
Q1 2023

Apr 10, 2023

SELL
$65.71 - $74.53 $26,283 - $29,812
-400 Reduced 8.49%
4,314 $299,000
Q4 2022

Jan 11, 2023

SELL
$68.48 - $81.09 $18,421 - $21,813
-269 Reduced 5.4%
4,714 $0
Q3 2022

Oct 13, 2022

BUY
$0.13 - $76.84 $2 - $1,383
18 Added 0.36%
4,983 $345,000
Q2 2022

Jul 25, 2022

SELL
$72.62 - $79.98 $11,110 - $12,236
-153 Reduced 2.99%
4,965 $362,000
Q1 2022

May 09, 2022

SELL
$61.48 - $73.72 $4,672 - $5,602
-76 Reduced 1.46%
5,118 $388,000
Q4 2021

Jan 18, 2022

BUY
$53.63 - $62.52 $51,967 - $60,581
969 Added 22.93%
5,194 $321,000
Q3 2021

Oct 20, 2021

BUY
$59.17 - $69.31 $249,993 - $292,834
4,225 New
4,225 $241,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Onyx Bridge Wealth Group LLC Portfolio

Follow Onyx Bridge Wealth Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Onyx Bridge Wealth Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Onyx Bridge Wealth Group LLC with notifications on news.